The effect of CYP2C9 gene polymorphisms on blood pressure lowering response to losartan in patients with essential hypertension
CUKUROVA MEDICAL JOURNAL, vol.47, no.3, pp.1015-1023, 2022 (ESCI, TRDizin)
- Publication Type: Article / Article
- Volume: 47 Issue: 3
- Publication Date: 2022
- Doi Number: 10.17826/cumj.1093761
- Journal Name: CUKUROVA MEDICAL JOURNAL
- Journal Indexes: Emerging Sources Citation Index (ESCI), Academic Search Premier, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Page Numbers: pp.1015-1023
- Keywords: Hypertension, losartan, CYP2C9, genetic polymorphism, pharmacogenetics, CLINICAL-RELEVANCE, VARIANTS, GENOTYPE
- Open Archive Collection: AVESIS Open Access Collection
- Hacettepe University Affiliated: Yes
Abstract
Purpose: In this study, the possible effects of CYP2C9 polymorphisms on the clinical response to losartan were investigated in a group of hypertensive patients.